Literature DB >> 9241563

Immunological and endocrinological abnormalities in paraneoplastic disorders with involvement of the autonomic nervous system.

M Riva1, A M Brioschi, R Marazzi, M F Donato, E Ferrante.   

Abstract

We report a series of four patients in whom the onset of systemic cancer was heralded by dysautonomic symptoms and a neurological non-metastatic complication mediated by immunological and endocrine factors. The series includes: a patient with acute leukaemia and autonomic sensory-motor polyradiculoneuropathy, a patient affected by colon carcinoma and autonomic neuropathy and limbic encephalitis, a patient with lung cancer and autonomic neuropathy and hypercalcaemic encephalopathy, a patient with small cell lung cancer associated with autonomic neuropathy in Lambert-Eaton Myasthenic Syndrome (LEMS) and syndrome of inappropriate ADH secretion (SIADH). We underline the prognostic importance and discuss the possible etiopathogenetic role of autonomic dysfunction, which is frequently associated with paraneoplastic neurologic syndromes of autoimmune and/or dysendocrine origin.

Entities:  

Mesh:

Year:  1997        PMID: 9241563     DOI: 10.1007/bf02048484

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  3 in total

1.  Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.

Authors:  S A Waterman
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

2.  A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy.

Authors:  Laura Attademo; Stefano De Falco; Mario Rosanova; Marcello Esposito; Federica Mazio; Francesca Foschini; Antonio Santaniello; Giovanni Fiore; Elide Matano; Fiore Manganelli; Chiara Carlomagno
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

3.  Integrated treatment for autonomic paraneoplastic syndrome improves performance status in a patient with small lung cell carcinoma: a case report.

Authors:  Tatsuya Ueno; Yukihiro Hasegawa; Rie Hagiwara; Tomoya Kon; Jin-Ichi Nunomura; Masahiko Tomiyama
Journal:  BMC Neurol       Date:  2018-11-10       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.